Navigation Links
Ambit Biosciences to Present at 30th Annual J.P. Morgan Healthcare Conference
Date:1/9/2012

SAN DIEGO, Jan. 9, 2012 /PRNewswire/ -- Ambit Biosciences Corporation today announced that the company is scheduled to present at the 30th Annual J.P. Morgan Healthcare Conference at 10 a.m. PST on Thursday, January 12, at The Westin St. Francis in San Francisco. Michael A. Martino, president and chief executive officer, will provide an overview of the company and an update about its clinical development programs, including quizartinib.

About Quizartinib

Quizartinib, formerly known as AC220, is being developed in collaboration between Ambit Biosciences and Astellas Pharma Inc. and is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor.  Quizartinib is currently under evaluation in a Phase 2 clinical trial as monotherapy treatment for adult and elderly patients with relapsed/refractory AML that have an internal tandem duplication (ITD) mutation in the FLT3 gene.

About Ambit Biosciences

Ambit Biosciences is a privately held biopharmaceutical company engaged in the development of a robust pipeline of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease and other indications. Ambit's lead compound, quizartinib (AC220), is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor, and is currently under clinical investigation in patients with relapsed or refractory AML. Ambit is developing quizartinib in collaboration with Astellas Pharma Inc. as part of a worldwide agreement to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications. In addition to quizartinib, Ambit's clinical pipeline includes AC430, an oral JAK2 inhibitor, and AC480, a pan-HER inhibitor.

Ambit's preclinical portfolio includes, CEP-32496, a BRAF inhibitor licensed to Cephalon, and a proprietary CSF1R inhibitor program. For more information, visit

SOURCE Ambit Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference
2. Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications
3. Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting
4. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
5. Ambit Biosciences Strengthens Board of Directors and Executive Team
6. Ambit Biosciences Initiates Two Phase I Clinical Trials
7. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
8. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
9. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
10. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... -- UBM Medica US announces that Endocrinology Network , ... who treat patients with type 2 diabetes ... insulin .  Nearly all patients with ... – daily injections of one or more insulin formulations—to ... of pancreatic beta cells. Insulin is a very effective ...
(Date:10/17/2014)...   ndd Medical Technologies , a leader in ... technology, announced that its EasyOne Pro® is now being ... a 140,000 square foot, 44-bed hospital with many outpatient ... serves a large number of Native Americans from several ... and beyond. A portion of its funding comes from ...
(Date:10/17/2014)... People often ask for real world CRT case ... this is that big pharma companies aren,t always willing to ... this together was therefore no easy task, but we are ... companies to put pen to paper and divulge the ins ... caveat - some have asked us to remain anonymous so ...
Breaking Medicine Technology:Endocrinology Network Features Special Coverage on Effective Use of Insulin 2Endocrinology Network Features Special Coverage on Effective Use of Insulin 3EasyOne Pro Mobile Respiratory Testing from ndd Medical Technologies Chosen by Choctaw Nation 2Pharma Cool Chain & CRT Benchmarking Report 2
... recent studies,suggest that over-consumption of fluoride can raise ... and the thyroid gland," reports,Scientific American editors (January ... shift," writes author Dan Fagin., "Fluoride, the ... added to,2/3 of public water supplies theoretically to ...
... Dec. 21 A new brain imaging,study by researchers ... shows that cigarette cravings in smokers who are deprived ... of the,brain. Using a novel method of measuring brain ... Neurology at Penn, this study is the,first to show ...
Cached Medicine Technology:'Second Thoughts about Fluoride,' Reports Scientific American 2'Brain Signature' for Cigarette Cravings Identified 2'Brain Signature' for Cigarette Cravings Identified 3
(Date:10/18/2014)... 2014 The famous review site Top10BestSEOHosting.com ... evaluating many web host suppliers carefully, today it announces ... Hosting suppliers in the first half of 2014. ... market. Its internet hosting package helps business companies and ... cost. As a top rated hosting provider, it insists ...
(Date:10/18/2014)... 19, 2014 The excellent ... Hostgator ( http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts ), JustHost and FatCow ... 2014. , “There are thousands of ... good suppliers are not too many. We ... are the most outstanding suppliers when it ...
(Date:10/18/2014)... Operators in the Carpet Cleaning ... cleaning services, such as steam cleaning, dry-cleaning and ... one to two years. According to IBISWorld industry ... during the peak of the global financial crisis, ... cleaning.” The upward trend in household discretionary income ...
(Date:10/18/2014)... 18, 2014 Market Research ... Industry, 2009-2019 is a professional and in-depth ... Chondroitin sulfate industry. The report firstly reviews ... its classification, application and manufacturing technology. The ... manufacturers of Chondroitin sulfate listing their product ...
(Date:10/18/2014)... (HealthDay News) -- Even determined dieters can fail if ... nearby, researchers say. Their new study included 240 ... (a combination of risk factors that increase the risk ... told by their doctors to make lifestyle changes, including ... were involved in a clinical trial comparing two dietary ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: HostMonster, GreenGeeks And FatCow Are The Best PHP Hosting Suppliers In The First Half Of 2014 2Health News:Top10BestSEOHosting.com: Best Reseller Hosting Companies Announced 2Health News:Carpet Cleaning Services in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Carpet Cleaning Services in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 2Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 3Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 4Health News:Dieters May Be Thwarted by Absence of Healthy Foods 2
... awarded a 63-year-old doctor of Indian origin a four-year ... patients over a 13-year //period between September 1991 and ... qualified in India, moved to Britain in 1973. He ... His one-man practice had 2,900 patients. He began his ...
... water filtration technique which is used to clean up agricultural ... an algae found in lakes and rivers. Engineers are extremely ... method, with a 95% success rate of removal of the ... country already use the technique, which couples activated carbon with ...
... 2,000 people are being recruited from Orkney, Scotland as a ... genes that cause osteoporosis. //The study is to be funded ... and Shapinsay, as well as those from the west of ... The study may cost ?240,000 over the next three years. ...
... (AMARRG), Dr David Rivett, said today that this week's announcement ... Medical Infrastructure Fund (RMIF) was a welcome piece of rare ... RMIF is designed to attract GPs to work in country ... scheme shows that the Government is getting serious about regional ...
... improve quality of care, say researchers in this ... recently recommended //certification of doctors to strengthen professional ... in the United States that allows doctors to ... standards required for licensing purposes. Certified status must ...
... been identified by Howard Hughes Medical Institute researcher Charles S. ... Health after seven years of working together to identify the ... tastes humans can sense -- sweet, bitter, and umami. ... primary gateway in all mammals for the detection of spoiled ...
Cached Medicine News:Health News:Indian Doctor in Britain Jailed for Molesting Patients 2Health News:Fresh Water Algae Filtered Out With Water Filtration Technique 2Health News:Fresh Water Algae Filtered Out With Water Filtration Technique 3Health News:New Study To Identify Osteoporosis Genes 2Health News:RMIF Boost a Boon for Rural Health 2Health News:Certification of UK Doctors Would Improve Quality of Care 2Health News:Sour Taste Sensors Identified 2Health News:Sour Taste Sensors Identified 3
... physicians looking for a traditional ... communications with electronic storage features, ... best of both worlds. It ... features of the Atria 3000 ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: